Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
John M. Rothman | M | 75 | 4 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Steve Hoffman | M | 61 | 11 years | |
Douglas Michels | M | 66 |
Johnson & Johnson Health Care Systems, Inc.
Johnson & Johnson Health Care Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Health Care Systems, Inc. provides account management and customer support services. The firm services include contract management, e-business and supply chain. It provides services to health care organizations, hospitals, physician networks and government customers. The company is headquartered in Piscataway, NJ | 6 years |
Michael Demurjian | M | 60 | 8 years | |
Ben Taylor | M | 46 | 3 years | |
James Biehl | M | 60 | 5 years | |
Donald DeGolyer | M | 63 | 4 years | |
James M. Hinson | M | 73 |
Aldagen, Inc.
Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | - |
Gerald H. Sokol | M | 81 | 8 years | |
Jonathan Eckard | M | 50 | 5 years | |
Tim Tyson | M | 71 | 7 years | |
Richard Cunningham | M | 54 | 2 years | |
Lyle A. Hohnke | M | 80 |
Aldagen, Inc.
Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | 4 years |
Tommy Thompson | M | 81 | 2 years | |
W. Amick | M | 81 |
Aldagen, Inc.
Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | 5 years |
Michele Korfin | F | 53 | 2 years | |
Christine Baker | F | 58 | - | |
Jan van Tornout | M | 68 | 1 years | |
Guiseppe Del Priore | M | 62 | 6 years | |
John Graham | M | 56 |
Johnson & Johnson-Merck Consumer Pharmaceuticals Co.
| 4 years |
Laurence Keller | M | - |
Aldagen, Inc.
Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | 2 years |
Renaat van den Hooff | M | 65 |
Johnson & Johnson-Merck Consumer Pharmaceuticals Co.
| 3 years |
Melanie Barstad | F | 71 |
Johnson & Johnson Health Care Systems, Inc.
Johnson & Johnson Health Care Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Health Care Systems, Inc. provides account management and customer support services. The firm services include contract management, e-business and supply chain. It provides services to health care organizations, hospitals, physician networks and government customers. The company is headquartered in Piscataway, NJ | 12 years |
Sandra M. Denarski | F | - |
Independence Technology LLC
Independence Technology LLC Medical DistributorsDistribution Services Independence Technology LLC manufactures electronic wheelchair. The company is located in Warren, NJ. | - |
William Edward Evans | M | 74 |
Aldagen, Inc.
Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | - |
Rick S. Kent | M | 74 |
Aldagen, Inc.
Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | 2 years |
Frank L. Porfido | M | 60 | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 27 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David P. Carberry
- Personal Network